Germline pathogenic mutations in BAP1 result in an autosomal dominant tumor predisposition syndrome, increasing the risk for uveal melanoma, mesothelioma, and renal cell carcinoma—predominantly clear cell—and at a younger median age compared to sporadic occurrences. This evidence concerns the gene BAP1 and mesothelioma.